‡ In these countries please contact our distributor

Independent Non-Executive Director - Michael A Friedman

Appointed Independent Non-Executive Director in April 2013 and Chair of the Compliance & Culture Committee in August 2014. Michael will be retiring from the Board at the Annual General Meeting on 11 April 2019 and will not stand for re-election. 

Career and Experience

Michael is medically trained, specialising in Internal medicine and Medical Oncology. He was formerly CEO of City of Hope in California, and also served as Director of the institution’s cancer centre and held the Irell & Manella Cancer Center. He was formerly Senior VP of research, medical and public policy for Pharmacia Corporation and also Deputy Commissioner and Acting Commissioner at the US Food and Drug Administration (FDA). He has served on a number of boards in a non-executive capacity and is currently a NED of Celgene Corporation, MannKind Corporation and Intuitive Surgical, Inc.

Skills and Competencies

Michael understands the fundamental importance of research, which is part of Smith & Nephew’s value creation process. His varied experience in both the public and private healthcare sectors have given him a deep insight and a highly respected career. In particular his work with the FDA and knowledge relating to US compliance provides the skillset required to Chair the Compliance & Culture Committee.


Board and committees of Smith & Nephew

More about matters reserved to the board, the roles of Chair, Chief Executive Officer & Senior Independent Director, and the terms of reference for board committees